Report Finder

All Sentinel reports, surveillance tools, FDA assessments, and communication materials may be searched using the options below. Search results can be further sorted by title, project status, and date posted by clicking on the relevant column header. If you wish to search for FDA Center assessments more specifically by medical product and health outcome, please go to the CDER Assessments and CBER Assessments pages.

E.g., 1/22/2020
E.g., 1/22/2020
Titlesort ascending Status FDA Center Date Posted
Serious Cutaneous Adverse Reaction (SCAR) Diagnoses Complete CDER 04/09/2012
Sequential TreeScan Signal Identification Methods Development In progress 12/11/2018
Sequential Surveillance for Drug Safety in a Regulatory Environment Complete 03/05/2018
Sequential Analysis of Gardasil 9 Safety Discontinued CBER 11/28/2018
Sentinel Medical Chart Review Gap Analysis Complete 04/18/2018
Sensitivity of Safety Analyses to Minor Changes in Specifications Applied to Test Case Complete 03/06/2018
Selgiline Use Complete CDER 01/10/2013
Self-Harm Algorithms Defined in "Neuropsychiatric Events following Montelukast Use: A Propensity Score Matched Analysis" Complete 08/19/2019
Selected Medications and Death, with Linkage of Mini-Sentinel Distributed Database with NDI+ Discontinued CDER 03/06/2018
Select Bisphosphonates and Select Outcomes of Interest Complete CDER 03/14/2015
Seizure following Ranolazine Use Complete CDER 01/03/2019
Seizure Algorithm Defined in "Seizure following Ranolazine Use: A Self-Controlled Risk Interval Analysis" Complete 04/24/2018
Risk of Acute Myocardial Infarction and Stroke among Carbidopa/Levodopa, Entacapone, and Carbidopa/Levodopa/Entacapone Users Complete CDER 03/27/2018
Rhabdomyolysis and/or Creatine Kinase Laboratory Results Following New Use of Statins or Angiotensin-Converting Enzyme Inhibitors Complete CDER 03/01/2018
Respiratory Syncytial Virus in a Pediatric Population Complete CDER 11/19/2019
Regional Enteritis and Ulcerative Enterocolitis Diagnoses Complete CDER 06/22/2012
Rapid Surveillance Capability: 2017-18 Seasonal Influenza Vaccines Surveillance Complete CBER 05/22/2019
Quinine Sulfate, Diltiazem and Selected Thrombotic Events Complete CDER 01/08/2014
Quantitative Bias Analysis Methodology Development Complete 08/04/2017
Quantifying Prevalence and Mortality Associated with Neonatal Enteroviral Sepsis (NES) Using Inpatient Data in FDA’s Sentinel System Complete CDER 11/27/2018
Pulmonary Arterial Hypertension and Interstitial Lung Disease Events Among Interleukin Inhibitor Users Complete CDER 12/03/2018
Propylthiouracil and Methimazole Use 2 Complete CDER 10/07/2013
Propylthiouracil and Methimazole Use Complete CDER 08/02/2012
PROMPT: Rivaroxaban Surveillance Complete CDER 01/31/2018
PROMPT: Mirabegron Surveillance Discontinued CDER 09/21/2016
Progressive Multifocal Leukoencephalopathy Diagnoses Complete CDER 04/26/2012
Progressive Multifocal Leukoencephalapathy Complete CDER 02/24/2015
Procedure Codes Related to Memory Gel Breast Implants Complete CDER 11/10/2014
Prevalent Dispensings of Ticagrelor (Brilinta) and Vortioxetine Hydrobromide (Brintellix) Complete CDER 04/23/2017
Prevalent and Incident Use of Testosterone Products In progress CDER 12/21/2017
Prevalent and Incident Use of SGLT2 Inhibitors In progress CDER 02/01/2018
Prevalent and Incident Use of Romiplostim In progress CDER 12/18/2017
Prevalent and Incident Use of Quinine Sulfate Complete CDER 01/08/2014
Prevalent and Incident Use of Pramipexole In progress CDER 02/25/2015
Prevalent and Incident Use of Isotretinoin In progress CDER 01/16/2018
Prevalent and Incident Use of Generic Name Kinase Inhibitors In progress CDER 03/08/2018
Prevalent and Incident Use of Fingolimod Complete CDER 03/28/2018
Prevalent and Incident Use of Acetazolamide In progress CDER 01/09/2014
Prevalent and Incident Dispensings of Ranolazine In progress CDER 02/26/2018
Prevalence and Incident Use of Promethazine Complete CDER 03/26/2018
Prevalence and Incidence of Progressive Multifocal Leukoencephalopathy (PML), Clostridium Difficile, and Cytomegalovirus (CMV) Diagnoses Complete CDER 06/04/2018
Postlicensure Medical Product Safety Data-Mining: Power Calculations for Bernoulli Data Complete CBER 12/22/2017
Pneumococcal Conjugate Vaccines and Kawasaki Disease Complete CBER 05/29/2014
Pilot Test of Sequential PSM Capabilities, Using ACEI/Beta Blockers and Angioedema In progress 06/15/2017
Phosphodiesterase Type 5 (PDE-5) Inhibitor Utilization Among Women Complete CDER 10/12/2018
Pertussis Cases in Infants Complete CBER 07/27/2017
Pegylated Products Use In progress CDER 10/06/2017
Pegylated Products Follow-Up Request Complete CDER 10/06/2017
Parkinson’s Disease Medication Use Complete CDER 06/07/2013
Parenteral Iron and Anaphylactoid Reactions Complete CDER 07/22/2016
Oxicam NSAIDs, Modafinil/Armodafinil, Sulfamothoxazole and Severe Cutaneous Adverse Reaction (SCAR) Events Complete CDER 06/07/2013
Outpatient Depressive Disorder Algorithm Defined in "Neuropsychiatric Events following Montelukast Use: A Propensity Score Matched Analysis" Complete 08/19/2019
Outcome-Based TreeScan Analyses (DrugSCAN) Complete 02/14/2017
Osteoporotic Fractures following Lupron Depot-PED Use: A Multiple Factor Matched Analysis In progress CDER 07/02/2019
Osteoporotic Fracture Algorithm Defined in "Osteoporotic Fractures following Lupron Depot-PED Use: A Multiple Factor Matched Analysis" Complete 07/02/2019
Oral Antifungal Use Complete CDER 11/20/2013
Optimal Propensity Score Matching Strategies for Subgroup Analyses Complete 03/15/2018
Optimal Initial Length of Opioid Prescription Complete CDER 02/01/2019
Opioid Medication Use Complete CDER 11/09/2014
Omalizumab Use In progress CDER 02/25/2015
Omalizumab or Montelukast Use Among Individuals with Asthma and Acute Myocardial Infarction, Stroke, Intracranial Hemorrhage, or Pulmonary Embolism Complete CDER 06/21/2016
Omalizumab and Montelukast Use Complete CDER 02/25/2015
Occurrence of Selected Vaccinations 1 Complete CBER 07/19/2012
Occurrence of Selected Pediatric Drugs 1 Complete CDER 06/07/2013
Occurrence of Selected HCPCS Codes 2 Complete CDER 08/02/2012
Occurrence of Selected HCPCS Codes 1 Complete CDER 08/30/2012
Occurrence of Selected Generic Drugs 9 Complete CDER 10/07/2013
Occurrence of Selected Generic Drugs 8 Complete CDER 07/17/2013
Occurrence of Selected Generic Drugs 7 Complete CDER 07/17/2013
Occurrence of Selected Generic Drugs 6 Complete CDER 01/07/2013
Occurrence of Selected Generic Drugs 5 Complete CDER 12/13/2012
Occurrence of Selected Generic Drugs 4 Complete CDER 12/13/2012
Occurrence of Selected Generic Drugs 3 Complete CDER 12/13/2012
Occurrence of Selected Generic Drugs 2 Complete CDER 08/02/2012
Occurrence of Selected Generic Drugs 13 Complete CDER 01/11/2018